DexCom Inc (DXCM) — Capital Reinvestment Ratio
DexCom Inc (DXCM) has a Capital Reinvestment Ratio of 0.35x as of December 2025, meaning it reinvests 0% of its operating cash flow ($294.00 Million) in capital expenditures ($101.90 Million). See DexCom Inc (DXCM) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
DexCom Inc Capital Reinvestment Ratio (2013–2025)
This chart tracks DexCom Inc's Capital Reinvestment Ratio across 13 annual periods. Check DXCM capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for DexCom Inc (2013–2025)
Year-by-year Capital Reinvestment Ratio for DexCom Inc from 2013 to 2025. For live market cap and broader valuation context, see DexCom Inc stock valuation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.25x | $1.44 Billion | $363.50 Million | ▼ -30.4% |
| 2024 | 0.36x | $989.50 Million | $358.80 Million | ▲ +14.7% |
| 2023 | 0.32x | $748.50 Million | $236.60 Million | ▼ -42.0% |
| 2022 | 0.54x | $669.50 Million | $364.80 Million | ▼ -38.0% |
| 2021 | 0.88x | $442.50 Million | $389.20 Million | ▲ +110.2% |
| 2020 | 0.42x | $475.60 Million | $199.00 Million | ▼ -26.9% |
| 2019 | 0.57x | $314.50 Million | $180.00 Million | ▲ +5.1% |
| 2018 | 0.54x | $123.20 Million | $67.10 Million | ▼ -24.1% |
| 2017 | 0.72x | $92.00 Million | $66.00 Million | ▼ -27.6% |
| 2016 | 0.99x | $56.20 Million | $55.70 Million | ▲ +45.8% |
| 2015 | 0.68x | $49.00 Million | $33.30 Million | ▼ -1.0% |
| 2014 | 0.69x | $23.60 Million | $16.20 Million | ▼ -79.1% |
| 2013 | 3.29x | $2.40 Million | $7.90 Million | — |